These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33877299)

  • 41. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
    Kar SP; Quiros PM; Gu M; Jiang T; Mitchell J; Langdon R; Iyer V; Barcena C; Vijayabaskar MS; Fabre MA; Carter P; Petrovski S; Burgess S; Vassiliou GS
    Nat Genet; 2022 Aug; 54(8):1155-1166. PubMed ID: 35835912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [TFH lymphoma and associated clonal hematopoiesis].
    Nann D; Fend F; Quintanilla-Martinez L
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of age and number of mutations on the size of clonal hematopoiesis.
    Wang K; Zhang W; Yi L; Zhao M; Li PY; Fu MH; Lin R; Zhu YM; Li JF; Yang WP; Fang H; Chen Z; Cai WW; Ren RB
    Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2319364121. PubMed ID: 38359296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonal hematopoiesis and risk for hematologic malignancy.
    Warren JT; Link DC
    Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population.
    van Zeventer IA; de Graaf AO; Salzbrunn JB; Nolte IM; Kamphuis P; Dinmohamed A; van der Reijden BA; Schuringa JJ; Jansen JH; Huls G
    Cancer Cell; 2023 Jun; 41(6):1017-1031.e4. PubMed ID: 37146604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis.
    Karner K; George TI; Patel JL
    Ann Lab Med; 2019 Nov; 39(6):509-514. PubMed ID: 31240877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease.
    Hecker JS; Hartmann L; Rivière J; Buck MC; van der Garde M; Rothenberg-Thurley M; Fischer L; Winter S; Ksienzyk B; Ziemann F; Solovey M; Rauner M; Tsourdi E; Sockel K; Schneider M; Kubasch AS; Nolde M; Hausmann D; Paulus AC; Lützner J; Roth A; Bassermann F; Spiekermann K; Marr C; Hofbauer LC; Platzbecker U; Metzeler KH; Götze KS
    Blood; 2021 Nov; 138(18):1727-1732. PubMed ID: 34139005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.
    Zhang Z; Sun J
    Adv Exp Med Biol; 2023; 1442():65-83. PubMed ID: 38228959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 60 Years of clonal hematopoiesis research: From X-chromosome inactivation studies to the identification of driver mutations.
    Ayachi S; Buscarlet M; Busque L
    Exp Hematol; 2020 Mar; 83():2-11. PubMed ID: 32001340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal Platelet Counts and Clonal Hematopoiesis in the General Population.
    Kamphuis P; van Bergen MGJM; van Zeventer IA; de Graaf AO; Dinmohamed AG; Salzbrunn JB; Schuringa JJ; van der Reijden BA; Huls G; Jansen JH
    Hemasphere; 2023 Jan; 7(1):e821. PubMed ID: 36698617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The crossroads of cancer therapies and clonal hematopoiesis.
    Singh A; Balasubramanian S
    Semin Hematol; 2024 Feb; 61(1):16-21. PubMed ID: 38403501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis.
    Nowakowska MK; Kim T; Thompson MT; Bolton KL; Deswal A; Lin SH; Scheet P; Wehner MR; Nead KT
    Am J Hematol; 2022 Apr; 97(4):411-420. PubMed ID: 35015316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.
    Dharan NJ; Yeh P; Bloch M; Yeung MM; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy JF; Woolley I; Pell C; Templeton DJ; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson SJ; Polizzotto MN; Dawson MA;
    Nat Med; 2021 Jun; 27(6):1006-1011. PubMed ID: 34099923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review.
    Calvillo-Argüelles O; Jaiswal S; Shlush LI; Moslehi JJ; Schimmer A; Barac A; Thavendiranathan P
    JAMA Cardiol; 2019 Apr; 4(4):380-387. PubMed ID: 30865214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
    Marshall CH; Gondek LP; Daniels V; Lu C; Pasca S; Xie J; Markowski MC; Paller CJ; Sena LA; Denmeade SR; Luo J; Antonarakis ES
    Prostate; 2024 Jul; 84(10):954-958. PubMed ID: 38641986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis.
    Stacey SN; Zink F; Halldorsson GH; Stefansdottir L; Gudjonsson SA; Einarsson G; Hjörleifsson G; Eiriksdottir T; Helgadottir A; Björnsdottir G; Thorgeirsson TE; Olafsdottir TA; Jonsdottir I; Gretarsdottir S; Tragante V; Magnusson MK; Jonsson H; Gudmundsson J; Olafsson S; Holm H; Gudbjartsson DF; Sulem P; Helgason A; Thorsteinsdottir U; Tryggvadottir L; Rafnar T; Melsted P; Ulfarsson MÖ; Vidarsson B; Thorleifsson G; Stefansson K
    Nat Genet; 2023 Dec; 55(12):2149-2159. PubMed ID: 37932435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Germline predisposition for clonal hematopoiesis.
    Kubota Y; Viny AD
    Semin Hematol; 2024 Feb; 61(1):61-67. PubMed ID: 38311514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes.
    Nead KT; Kim T; Joo L; McDowell T; Wong J; Chan IC; Brock E; Zhao J; Xu T; Tang C; Lee CL; Abe JI; Bolton KL; Liao Z; Scheet P; Lin SH
    Blood Adv; 2024 Jun; ():. PubMed ID: 38830141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.